Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 4 of 8 for:    Breast Cancer | syndax [Lead]

Phase 2 Study of Fulvestrant With and Without Entinostat in Postmenopausal Women With ER+ Advanced Breast Cancer (ENCORE305)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02115594
Recruitment Status : Withdrawn (Internal decision)
First Posted : April 16, 2014
Last Update Posted : October 8, 2014
Sponsor:
Information provided by (Responsible Party):
Syndax Pharmaceuticals

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Estimated Primary Completion Date : December 2015
Estimated Study Completion Date : June 2016